Anjali LabTech Revamps IPO Plans with Updated Filing for Rs 1,225 Crore Lab-Grown Diamond Offering.

Anjali LabTech Ltd, a manufacturer of lab-grown diamonds, is set to make its debut in the Indian IPO market with a proposed Initial Public Offering (IPO) aimed at raising ₹1,225 crore. The IPO consists of a fresh issue of shares amounting to ₹925 crore alongside an Offer For Sale (OFS) of ₹300 crore by the promoters. The updated Draft Red Herring Prospectus (DRHP) indicates that this move comes after receiving approval from the Securities and Exchange Board of India (SEBI) earlier in the year. The company may also consider a pre-IPO placement round of up to ₹185 crore, which could adjust the total fresh issue amount accordingly.

Anjali LabTech, founded in 2021, has established itself as a vertically integrated player within the lab-grown diamond industry, operating seven manufacturing facilities in Surat, Gujarat. The proceeds from the IPO are earmarked for several strategic uses, including funding capital expenditure specifically for manufacturing enhancements and the installation of MPCVD machines to grow rough lab-grown diamonds in-house, as well as for constructing Anjali Corporate House. Additionally, the funds will be allocated to reduce debt and cover general corporate requirements, establishing a strong foothold in a rapidly growing sector.

The grey market sentiment surrounding Anjali LabTech’s IPO is cautiously optimistic, reflecting confidence in the expanding lab-grown diamond market in India. For retail investors, this IPO represents an opportunity to invest in a company positioned within a niche yet burgeoning industry. The growth potential of lab-grown diamonds, coupled with the company’s integrated production capabilities, may lead to favorable returns in the long run, making it an attractive addition to investment portfolios.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)